Literature DB >> 1626076

Antibodies to histones in systemic lupus erythematosus and drug-induced lupus syndromes.

M Monestier1, B L Kotzin.   

Abstract

Antihistone antibodies are some of the most frequent autoantibodies in rheumatic diseases and can represent useful diagnostic markers in some autoimmune syndromes. Histone epitopes are often located in accessible regions of chromatin or are conformational determinants resulting from the association of several components. These observations and studies with murine models of lupus strongly support the view that histones play a direct stimulatory role in triggering autoantibody production.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1626076

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  15 in total

Review 1.  Nucleic acid sensing receptors in systemic lupus erythematosus: development of novel DNA- and/or RNA-like analogues for treating lupus.

Authors:  P Lenert
Journal:  Clin Exp Immunol       Date:  2010-05-07       Impact factor: 4.330

2.  Divergent members of a single autoreactive B cell clone retain specificity for apoptotic blebs.

Authors:  Indira Neeli; Mekel M Richardson; Salar N Khan; Danielle Nicolo; Marc Monestier; Marko Z Radic
Journal:  Mol Immunol       Date:  2006-11-03       Impact factor: 4.407

Review 3.  Anti-DNA, antihistone, and antinucleosome antibodies in systemic lupus erythematosus and drug-induced lupus.

Authors:  G Q Shen; Y Shoenfeld; J B Peter
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

4.  Structural models of antibody variable fragments: a method for investigating binding mechanisms.

Authors:  S Petit; F Brard; G Coquerel; G Perez; F Tron
Journal:  J Comput Aided Mol Des       Date:  1998-03       Impact factor: 3.686

Review 5.  Genetic dissection of lupus nephritis in murine models of SLE.

Authors:  E K Wakeland; L Morel; C Mohan; M Yui
Journal:  J Clin Immunol       Date:  1997-07       Impact factor: 8.317

Review 6.  Clinical relevance of autoantibodies in systemic rheumatic diseases.

Authors:  M J Fritzler
Journal:  Mol Biol Rep       Date:  1996       Impact factor: 2.316

7.  The pentapeptide PLNPK inhibits systemic lupus erythematosus-associated renal damage.

Authors:  Jun-qiang Lv; Wen Zhang; Song Wang; Lin Zhao; Rui Ma; Jin-wei Hu; Li-juan Wang; Jie Meng; Chun-lei Zhou; Gang Lin; Rong Lu; Zhi Yao
Journal:  Inflamm Res       Date:  2010-07-01       Impact factor: 4.575

8.  Anti-subnucleosome reactivities in systemic lupus erythematosus (SLE) patients and their first-degree relatives.

Authors:  C Mohan; F Liu; C Xie; R C Williams
Journal:  Clin Exp Immunol       Date:  2001-01       Impact factor: 4.330

9.  Major peptide autoepitopes for nucleosome-specific T cells of human lupus.

Authors:  L Lu; A Kaliyaperumal; D T Boumpas; S K Datta
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

10.  Susceptibility of T cell receptor-alpha chain knock-out mice to ultraviolet B light and fluorouracil: a novel model for drug-induced cutaneous lupus erythematosus.

Authors:  T Yoshimasu; T Nishide; N Seo; A Hiroi; T Ohtani; K Uede; F Furukawa
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.